GGrantIndex
Sort

261,768 grants matching gene therapy

Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

$1,070,498
Timothy W Schacker · University Of Minnesota · U01 · FY2016 · AI

Gene Therapy for Metabolic Disorders

$1,070,384
University Of Minnesota Twin Cities · P01 · FY2005 · HD

NIDCD Core for Clinical Research and Care

$1,070,383
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2009 · DC

Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development

$1,070,336
Charles Wang · Loma Linda University · U01 · FY2024 · DA

Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis

$1,070,303
David A Stoltz · University Of Iowa · R01 · FY2017 · HL

TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP

$1,070,294
Southern Research Institute · U19 · FY2003 · CA

Depletion of Dendritic Cells by Immunotoxin as Therapy for Myocardial Infarction

$1,070,291
Michael W Fanger · Celdara Medical, Llc · R44 · FY2012 · HL

Aging Intervention Program

$1,070,235
Rafael De Cabo · National Institute On Aging · ZIA · FY2024 · AG

Neonatal porcine islet xenografts for the treatment of type 1 diabetes

$1,070,151
Allan D. Kirk · Duke University · U01 · FY2020 · AI

Development of a Personalized Medicine Interface for the Safe and Effective Treat

$1,070,149
Kristen Keeling Reynolds · Pharmacogenetics Diagnostic Laboratories · R44 · FY2011 · HL

Targeting DNA damage response pathways for the treatment of advanced lung cancer

$1,070,134
Diane S Keeney · Cumberland Pharmaceuticals, Inc. · R44 · FY2019 · CA

RESTORATION OF APOPTOSIS IN CANCER

$1,070,099
University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA

Medical Retina Fellowship

$1,070,068
Catherine Cukras · National Eye Institute · ZIE · FY2023 · EY

Development of New Hypoxic Cytotoxins for Cancer Therapy

$1,070,022
John Martin Brown · Stanford University · P01 · FY2006 · CA

Bioinformatics

$1,069,886
Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES

The Investigation of disease causing genes in C. elegans

$1,069,880
Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic Platform

$1,069,803
Aaron R. Hawkins · Brigham Young University · R01 · FY2016 · AI

Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria

$1,069,709
Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2008 · AI

Profiling cancer neoantigen repertoires and validating immunotherapy targets

$1,069,555
Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA

IN UTERO SMALL AND LARGE ANIMAL RESOURCE CORE

$1,069,284
Alan W. Flake · Children'S Hosp Of Philadelphia · U19 · FY2023 · NS

OFF-TARGET RESOURCE CORE

$1,069,284
Xiao Wang · Children'S Hosp Of Philadelphia · U19 · FY2023 · NS

LEAD PROJECT 1: PHENYLKETONURIA (PKU)

$1,069,284
Kiran Musunuru · Children'S Hosp Of Philadelphia · U19 · FY2023 · NS

PROJECT 3: MUCOPOLYSACCHARIDOSIS TYPE 1 (MPS1)

$1,069,283
Beverly L Davidson · Children'S Hosp Of Philadelphia · U19 · FY2023 · NS

PROJECT 2: HEREDITARY TYROSINEMIA TYPE 1 (HT1)

$1,069,283
William H. Peranteau · Children'S Hosp Of Philadelphia · U19 · FY2023 · NS

Understanding the role of tumor microenvironment in low grade glioma progression to malignancy

$1,069,188
Long Cai · California Institute Of Technology · U01 · FY2024 · CA